𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas

✍ Scribed by Ronald E. Warnick; Michael D. Prados; Ellen E. Mack; Kym L. Chandler; François Doz; Jane E. Rabbitt; Mary K. Malec

Publisher
Springer US
Year
1994
Tongue
English
Weight
487 KB
Volume
19
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II evaluation of high-dose intrave
Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure
✍ Alexander M. Spence; Mitchel S. Berger; Robert B. Livingston; Francis Ali-Osman; 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 347 KB

Twenty-one patients with recurrent malignant glioma who had failed prior chemotherapy with nitrosoureas were treated with high-dose intravenous cisplatin on days 1 and 8 of successive 4 week cycles. Fourteen patients were evaluable for response. Four patients showed partial responses; mean time to t

A Phase I/II study of carboplatin combin
A Phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas
✍ Jeffrey Allen; Joao Siffert; Bernadine Donahue; Anita Nirenberg; Regina Jakacki; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## BACKGROUND. Brainstem gliomas often respond to radiotherapy but long term disease control is exceptional. The concomitant administration of a chemotherapy agent with radiosensitizing properties such as carboplatin may increase the efficacy of radiotherapy.

Phase II study of weekly intravenous men
Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults
✍ David J. Stewart; Herman Hugenholtz; Vasco F. DaSilva; Brian G. Benoit; Michael 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 435 KB

Twenty patients with astrocytomas recurrent after surgery + radiation were treated on a phase II protocol of the new anthracycline derivative menogaril 115 mg/m 2 administered intravenously once per week. Sixteen patients were evaluable for treatment efficacy. No patient achieved a major therapeutic